These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 2354455
1. Radiosensitivity of skin fibroblasts from atomic bomb survivors with and without breast cancer. Ban S, Setlow RB, Bender MA, Ezaki H, Hiraoka T, Yamane M, Nishiki M, Dohi K, Awa AA, Miller RC. Cancer Res; 1990 Jul 01; 50(13):4050-5. PubMed ID: 2354455 [Abstract] [Full Text] [Related]
2. X-ray sensitivity of fibroblast cell strains derived from atomic bomb survivors with and without breast cancer. Ban S, Setlow RB, Ezaki H, Hiraoka T, Yamane M, Nishiki M, Dohi K. J Radiat Res; 1991 Mar 01; 32 Suppl():330-8. PubMed ID: 1762123 [Abstract] [Full Text] [Related]
3. In vitro radiosensitivity of fibroblasts from thyroid and skin cancer patients treated with X-rays for tinea capitis. Ron E, Tarone RE, Modan B, Chaki R, Alfandary E, Parry DM, Makar M, Setlow N, Mulvihill JJ, Miller RW. Cancer Epidemiol Biomarkers Prev; 1994 Mar 01; 3(3):229-32. PubMed ID: 8019372 [Abstract] [Full Text] [Related]
4. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K. Prev Med; 1997 Mar 01; 26(1):144-53. PubMed ID: 9010910 [Abstract] [Full Text] [Related]
5. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model. Little MP. Int J Radiat Biol; 2002 Mar 01; 78(3):145-63. PubMed ID: 11869470 [Abstract] [Full Text] [Related]
6. Cancer and non-cancer effects in Japanese atomic bomb survivors. Little MP. J Radiol Prot; 2009 Jun 01; 29(2A):A43-59. PubMed ID: 19454804 [Abstract] [Full Text] [Related]
7. Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. Land CE, Boice JD, Shore RE, Norman JE, Tokunaga M. J Natl Cancer Inst; 1980 Aug 01; 65(2):353-76. PubMed ID: 6931253 [Abstract] [Full Text] [Related]
8. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Howe GR, McLaughlin J. Radiat Res; 1996 Jun 01; 145(6):694-707. PubMed ID: 8643829 [Abstract] [Full Text] [Related]
9. Breast cancer among atomic bomb survivors--the relationship of prognosis to pathologic findings. Tokunaga M. Acta Pathol Jpn; 1979 Mar 01; 29(2):197-209. PubMed ID: 552793 [Abstract] [Full Text] [Related]
12. In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. Loeffler JS, Harris JR, Dahlberg WK, Little JB. Radiat Res; 1990 Feb 01; 121(2):227-31. PubMed ID: 2305041 [Abstract] [Full Text] [Related]
14. Breast cancer incidence among atomic bomb survivors: implications for radiobiologic risk at low doses. Land CE, McGregor DH. J Natl Cancer Inst; 1979 Jan 01; 62(1):17-21. PubMed ID: 281571 [No Abstract] [Full Text] [Related]
16. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima. Kodama Y, Ohtaki K, Awa AA, Nakano M, Itoh M, Nakamura N. Radiat Res; 1999 Nov 01; 152(5):558-62. PubMed ID: 10521934 [Abstract] [Full Text] [Related]